Severe asthma and disease heterogeneity in chronic rhinosinusitis with nasal polyps
Annals of Clinical and Analytical Medicine · 20.03.2026 · 17 (suppl2) · 157-161
DOI: 10.4328/acam.50053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Analytical Medicine, erschienen am 20.03.2026. Verfasst von Şeyma Özden und 1 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Aim
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a heterogeneous inflammatory disease frequently associated with asthma, particularly severe asthma, which may influence disease phenotype and prognosis. However, real-world data on how severe asthma affects the clinical, inflammatory, and radiological features of CRSwNP remain limited.
Methods
This single-center, retrospective, observational cohort study included adult patients diagnosed with CRSwNP between January 2020 and June 2024. Patients were classified according to the presence or absence of comorbid severe asthma, defined by Global Initiative for Asthma (GINA) criteria. Demographic characteristics, comorbidities, inflammatory biomarkers (peripheral blood eosinophil count [PBEC] and serum total IgE), symptom burden (VAS and SNOT-22), and radiological severity assessed by the Lund–Mackay (LM) score were compared between groups.
Results
Among 52 patients included, 37 (71.2%) had comorbid severe asthma. Patients with severe asthma showed significantly higher PBEC (p = 0.045), while serum total IgE levels were comparable between groups. Obesity (65.7% vs 26.7%, p = 0.012) and nonsteroidal anti-inflammatory drug–exacerbated respiratory disease (NERD) (45.9% vs 6.7%, p = 0.006) were more prevalent in the asthma group. In contrast, symptom severity and radiological disease extent did not differ significantly.
Conclusion
CRSwNP patients with comorbid severe asthma display a distinct phenotype marked by increased systemic eosinophilia and higher rates of NERD and obesity, despite similar symptom burden and radiological severity. These findings support integrating asthma severity and inflammatory biomarkers into multidimensional risk stratification and personalized management of CRSwNP.
Zitieren
APA
Özden, Ş., & Tepetam, F. M. (2026). Severe asthma and disease heterogeneity in chronic rhinosinusitis with nasal polyps. Annals of Clinical and Analytical Medicine, 17(suppl2), 157-161. https://doi.org/10.4328/acam.50053
Vancouver
Özden Ş, Tepetam FM. Severe asthma and disease heterogeneity in chronic rhinosinusitis with nasal polyps. Annals of Clinical and Analytical Medicine. 2026;17(suppl2):157-161. doi:10.4328/acam.50053
BibTeX
@article{zden2026,
author = {Özden, Şeyma and Tepetam, Fatma Merve},
title = {Severe asthma and disease heterogeneity in chronic rhinosinusitis with nasal polyps},
journal = {Annals of Clinical and Analytical Medicine},
year = {2026},
volume = {17},
number = {suppl2},
pages = {157--161},
doi = {10.4328/acam.50053}
}
EUVIMED